- Issuer ticker
-
BSX
- Reported as of
-
10 Aug 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
11 Aug 2026, 16:39:29 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Susan Thompson, Attorney-in-Fact
Key filing fact
Jonathan Monson filed Form 4 for BOSTON SCIENTIFIC CORP (BSX) on 11 Aug 2026.
Key facts
- This page summarizes Jonathan Monson's Form 4 filing for BOSTON SCIENTIFIC CORP (BSX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Aug 2026, 16:39.
Change
- Previous filing in this sequence was filed on 02 Jul 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001779170
Primary reporting owner
Monson Jonathan
- Relationship
-
EVP and CFO
- Address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH
- Signature
- /s/ Susan Thompson, Attorney-in-Fact
- Signature date
- 11 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BSX
transaction
Common Stock
Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
- Transaction value
- Shares
- +9,908
- Change %
- Price
-
$50.46*
- Shares after
- 9,908
- Date
- 10 Aug 2026
- Ownership
- By 401(k)
- Footnotes
- F1
BSX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 39,063
- Date
- 10 Aug 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote